Volume 18 Number 3

This issue has a mini focus on transcatheter valve implantation (TAVI) with a report evaluating 3-year outcomes comparing patients with bicuspid aortic or tricuspid valve stenosis treated by TAVI; an article investigating coronary access after TAVI treatment of either bicuspid or tricuspid aortic valves. In valvular disease, an article on managing mitral regurgitation patients screened for transcatheter mitral valve implantation (TMVI), comparing outcomes with bailout-transcatheter edge-to-edge repair or medical therapy; In interventions for stroke, understanding device-related thrombus following left atrial appendage occlusion (LAAO). In coronary interventions, a cost-effectiveness analysis from the FLOWER-MI trial on fractional flow reserve-guided vs angiography-guided multivessel revascularisation in STEMI patients; first-in-man experience with the NeVa device to manage large thrombus burden in ACS patients; predicting plaque progression using near-infrared spectroscopy (NIRS); the Radiaction Shielding System, a novel robotic device to shield cath lab personnel from radiation, and more...